Radiation segmentectomy: A novel approach to increase safety and efficacy of radioembolization

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 1, 2011, Pages 163-171

  Riaz, Ahsun ^a   Gates, Vanessa L ^a   Atassi, Bassel ^a   Lewandowski, Robert J ^a   Mulcahy, Mary F ^a   Ryu, Robert K ^a   Sato, Kent T ^a   Baker, Talia ^b   Kulik, Laura ^a   Gupta, Ramona ^a   Abecassis, Michael ^b   Benson III, Al B ^a   Omary, Reed ^a   Millender, Laura ^a   Kennedy, Andrew ^c   Salem, Riad ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Wake Radiology Oncology   (United States)

Author keywords

Hepatocellular carcinoma; Radiation segmentectomy; Radioembolization

Indexed keywords

CONFIDENCE INTERVAL; HEPATOCELLULAR CARCINOMA; HIGH DOSE; LIVER VOLUME; MEDIAN RADIATION; MEDIAN SURVIVAL; NON-UNIFORM DISTRIBUTION; NONUNIFORM; NOVEL TECHNIQUES; POST TREATMENT; RADIOEMBOLIZATION; TREATMENT VOLUMES; UNIFORM DISTRIBUTION;

TOXICITY; TUMORS;

RADIATION;

BILIRUBIN; MACROSALB TC 99M; YTTRIUM 90;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; DOSIMETRY; FATIGUE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER NECROSIS; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SEGMENTECTOMY; TREATMENT RESPONSE; TUMOR VOLUME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONFIDENCE INTERVALS; EMBOLIZATION, THERAPEUTIC; FEMALE; GUIDELINES AS TOPIC; HEPATIC ARTERY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; NECROSIS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TUMOR BURDEN; YTTRIUM RADIOISOTOPES;

EID: 78649989722     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.10.062     Document Type: Article

References (36)

1. H.B. El-Serag Hepatocellular carcinoma and hepatitis C in the United States Hepatology 36 2002 S74 S83
2. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
3. J.M. Llovet, S. Ricci, and V. Mazzaferro Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
4. R.T. Poon, S.T. Fan, and F.H. Tsang Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective Ann Surg 235 2002 466 486
5. L.A. Dawson, and C. Guha Hepatocellular carcinoma: Radiation therapy Cancer J 14 2008 111 116
6. J.C. Cheng, J.K. Wu, and P.C. Lee Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease Int J Radiat Oncol Biol Phys 60 2004 1502 1509
7. N. Fukumitsu, S. Sugahara, and H. Nakayama A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma Int J Radiat Oncol Biol Phys 74 2009 831 836
8. B. Emami, J. Lyman, and A. Brown Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 1991 109 122
9. L.A. Dawson, and R.K. Ten Haken Partial volume tolerance of the liver to radiation Semin Radiat Oncol 15 2005 279 283
10. T.S. Lawrence, R.K. Ten Haken, and M.L. Kessler The use of 3-D dose volume analysis to predict radiation hepatitis Int J Radiat Oncol Biol Phys 23 1992 781 788
11. T.S. Lawrence, M.L. Kessler, and J.M. Robertson 3-D conformal radiation therapy in upper gastrointestinal cancer. The University of Michigan experience Front Radiat Ther Oncol 29 1996 221 228
12. L.M. Kulik, B.I. Carr, and M.F. Mulcahy Safety and efficacy of (90)Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis Hepatology 47 2007 71 81
13. R. Salem, and K.G. Thurston Radioembolization with 90yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: Part 1: Technical and methodologic considerations J Vasc Interv Radiol 17 2006 1251 1278 (Pubitemid 44259009)
14. J.Y. Young, T.K. Rhee, and B. Atassi Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma J Vasc Interv Radiol 18 2007 1375 1382
15. J. Bruix, J.M. Llovet, and A. Castells Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution Hepatology 27 1998 1578 1583
16. J.M. Llovet, J. Fuster, and J. Bruix The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma Liver Transpl 10 2004 S115 S120
17. H.B. El-Serag, J.A. Marrero, and L. Rudolph Diagnosis and treatment of hepatocellular carcinoma Gastroenterology 134 2008 1752 1763
18. L. Fischer, M. Thorn, and J.O. Neumann The segments of the hepatic veins - is there a spatial correlation to the Couinaud liver segments? Eur J Radiol 53 2005 245 255
19. M.D.S. Nordion TheraSphere Yttrium-90 microspheres package insert. Kanata 2004 MDS Nordion Ontario, Canada
20. E.D. Grady, S.P. Auda, and W.V. Cheek Vasoconstrictors to improve localization of radioactive microspheres in the treatment of liver cancer J Med Assoc Ga 70 1981 791 795
21. J.L. Russell, J.L. Carden, and H.L. Herron Dosimetry calculations for yttrium-90 used in the treatment of liver cancer Endocurietherapy/Hyperthermia Oncology 4 1988 171 186
22. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
23. World Health Organization WHO handbook for reporting results of cancer treatment. WHO offset publication no. 48 1979 WHO Geneva
24. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
25. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
26. T. Nomiya, H. Tsuji, and N. Hirasawa Carbon ion radiation therapy for primary renal cell carcinoma: Initial clinical experience Int J Radiat Oncol Biol Phys 72 2008 828 833
27. L.A. Dawson, D. Normolle, and J.M. Balter Analysis of radiation-induced liver disease using the Lyman NTCP model Int J Radiat Oncol Biol Phys 53 2002 810 821
28. M. Langer, S.S. Morrill, and R. Lane A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities Int J Radiat Oncol Biol Phys 41 1998 451 457
29. R.C. Gaba, R.J. Lewandowski, and L.M. Kulik Radiation lobectomy: Preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization Ann Surg Oncol 16 2009 1587 1596
30. J.A. Ingold, G.B. Reed, and H.S. Kaplan Radiation hepatitis Am J Roentgenol Radium Ther Nucl Med 93 1965 200 208
31. W.Y. Lau, T.W. Leung, and S. Ho Diagnostic pharmaco-scintigraphy with hepatic intra-arterial technetium-99 m macroaggregated albumin in the determination of tumour to non-tumour uptake ratio in hepatocellular carcinoma Br J Radiol 67 1994 136 139
32. S. Ho, W.Y. Lau, and T.W. Leung Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin Br J Radiol 70 1997 823 828
33. A.M. Campbell, I.H. Bailey, and M.A. Burton Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy Phys Med Biol 45 2000 1023 1033
34. S. Ho, W.Y. Lau, and T.W. Leung Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours Eur J Nucl Med 23 1996 947 952
35. E. Ben-Josef, D. Normolle, and W.D. Ensminger Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies J Clin Oncol 23 2005 8739 8747
36. A. Riaz, R.J. Lewandowski, and L.M. Kulik Complications following radioembolization with yttrium-90 microspheres: A comprehensive literature review J Vasc Interv Radiol 20 2009 1121 1130 quiz 1131